Author(s)

Hamilton dos Prazeres Tavares^1*, Mariana Alvarez Arantes¹, Suelma Beatriz Marques Prata Tavares², Joelcio Francisco Abbade³, D. C. D. Meirelles dosDébora Cristina Damasceno Meirelles dos Santos⁴, Iracema de Mattos Paranhos Calderon⁵, Marilza Vieira Cunha Rudge⁵

¹PhD Student in Gynecology, Obstetrics and Mastology at the Botucatu Medical School, Unesp, Paulista State University, Botucatu, SP, Brazil.
²Medical Specialist in Gynaecology and Obstetrics and Boss of Department of Gynecology and Obstetrics of the Municipal Hospital of Huambo, Huambo, Angola.
³Assistant Professor of Obstetrics, Botucatu Medical School, Unesp, Paulista State University, Botucatu, SP, Brazil.
⁴PhD, Department of Gynecology and Obstetrics, Laboratory of Experimental Research on Gynecology and Obstetrics, Botucatu Medical School, Unesp, Paulista State University, Botucatu, SP, Brazil.
⁵Full Professor of Obstetrics in Botucatu Medical School, Unesp, Paulista State University, Botucatu, SP, Brazil.

Background: The metabolic syndrome affects more and more global people. Although it shows increasing prevalence in general population, the syndrome affects more women than men, what makes its risk of being developed during pregnancy period. Also, possible perinatal adverse effects are always lurking. Objective: the objective was demonstrated what’s new in literature on metabolic syndrome and pregnancy. Methods: A literature review was performed to extract the articles published on metabolic syndrome and pregnancy, its prevalence, obstetrical complications and its perinatal adverse effects. This review was conducted by online researching in PubMed, Lilacs, Medline, Embase, Scopus, Medscape, Libertas Academica and CINAHL database, Science database and also by researches in books. 27 selected articles on metabolic syndrome after this research were all published between 1988 and 2015. Results: Among those 27 articles and two books studied, SM rate in obstetric population ranged from 3% to 42% depending on the previously manifested components of the syndrome, age and region. Women with previously manifested components showed more adverse perinatal effects. Conclusion: Women with pregestational DM or SM and SM develop more during pregnancy, obstetric complications and adverse perinatal outcomes.

Metabolic Syndrome, Pregnancy, Adverse, Perinatal Outcomes

Tavares, H. , Arantes, M. , Tavares, S. , Abbade, J. , Santos, D. , Calderon, I. and Rudge, M. (2015) Metabolic Syndrome and Pregnancy, Its Prevalence, Obstetrical and Newborns Complications. Open Journal of Obstetrics and Gynecology, 5, 618-625. doi: 10.4236/ojog.2015.511087.